Condition: Benign Prostatic Hyperplasia · Varicocele Grade II · Varicocele Grade III · Sponsor: Vivifi Medical
The study objective is to evaluate the safety and feasibility of the Vivifi's Treatment. The Vivifi's Treatment presents an innovative approach for addressing benign prostatic hyperplasia (BPH) as well as clinical/subclinical varicoceles in men. The scientific rationale for conducting this study is to assess the safety and feasibility of the Vivifi's Treatment (a surgical procedure) as a therapeutic intervention for patients with BPH.
This description comes directly from the study's public registry record.
Yunlong Zhang, Master of Science · 669-203-9308 · pzhang@rqmplus.com
Tushar Sharma, CEO of Vivifi (Study sponsor) · tushar@vivifimedical.com
Always discuss trial participation with your own doctor first.
| Hospital Paitilla | Panama City, Provincia de Panamá, Panama | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06424912